Thyrotropin receptor antibodies in black South African patients with Graves' disease and their response to medical therapy

Journal of Endocrinological Investigation

Volumn 21, Issue 11, 1998, Pages 771-774

  Zouvanis, M ^a   Panz, V R ^a   Kalk, W J ^a   Joffe, B I ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

Antibodies; Carbimazole; Graves' disease; Thyroglobulin antibodies; Thyroid microsomal; Thyrotropin receptor antibodies

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; MICROSOME ANTIBODY; THYROGLOBULIN ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAVES DISEASE; HUMAN; MALE; NEGRO; PROSPECTIVE STUDY;

EID: 0032422119     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03348044     Document Type: Article

References (11)

1. Kalk W.J. Thyrotoxicosis in urban black Africans: a rising incidence. East Afr. Med. J. 58: 109, 1981.
2. Kalk W.J., Kalk J. Incidence and causes of hyperthyroidism in blacks. S. Afr. Med. J. 75: 114, 1989.
3. Kalk W.J., Berzin M., Wing J. Drug therapy for Graves' disease in blacks - very low rates of remission. S. Afr. Med. J. 73: 284, 1988.
4. Hashizume K., Ichikawa K., Sakurai K., Suzuki S., Takeda T., Kobayashi M., Miyamoto T., Arai M., Nagasawa T. Administration of thyroxine in treated Graves' disease: effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N. Engl. J. Med. 324: 947, 1991.
5. Southgate K., Creagh F., Teece M., Kingswood C., Rees Smith B. A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin. Endocrinol. (Oxf.) 20: 539, 1984.
6. Kalk W.J., Santos J.E.C. Thyroid antibodies in Africans with diffuse toxic goitre: response to medical therapy. In: Drexhage H.A., Wiersinga W.M., (Eds.) The thyroid and autoimmunity. Elsevier Science Publishers BV, Amsterdam, 1986, p. 55.
7. Paschke R., Vogg M., Swillens S., Usadel K.H. Correlation of microsomal antibodies with the intensity of the intrathyroidal autoimmune process in Graves' disease. J. Clin. Endocrinol. Metab. 77: 939, 1993.
8. Cho B.Y., Shong M.H., Yi K.H., Lee H.K., Koh C.S., Min H.K. Evaluation of serum basal thyrotropin levels and thyrotropin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease. Clin. Endocrinol. (Oxf.) 36: 585, 1992.
9. Rittmaster R.S., Zwicker H., Abbott B.C., Douglas R., Givner M.L., Gupta M.K., Lehmann L., Reddy S., Salisbury S.R., Shlossberg A.H., Tan M.H., York S.E. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease. J. Clin. Endocrinol. Metab. 81: 3283, 1996.
10. Feldt-Rasmussen U., Schleusener H., Carayon P. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. J. Clin. Endocrinol. Metab. 78: 98, 1994.
11. Braverman L.E. Is there one successful antithyroid regimen for Graves' disease? Lancet 348: 679, 1996.